Tecan Group stock

TECN · SIX · CHF

Compare Tecan Group
CHF 238.60Change from previous close: −2.13%Absolute change: −CHF 5.20

Close · November 20, 2026

Price history

+79.40% over the period

1 year: from CHF 133.00 (November 20, 2025) to CHF 238.60 (November 20, 2026), +79.40%.

Show chart data

Closing prices adjusted for splits: the last close of each month.

DateClose
November 20, 2026CHF 238.60
October 30, 2026CHF 247.00
September 30, 2026CHF 234.40
August 31, 2026CHF 197.60
July 31, 2026CHF 186.10
June 30, 2026CHF 161.80
May 29, 2026CHF 155.40
April 30, 2026CHF 117.70
March 31, 2026CHF 133.40
February 27, 2026CHF 136.20
January 30, 2026CHF 136.00
December 30, 2025CHF 128.50
November 28, 2025CHF 138.40
November 20, 2025CHF 133.00

At a glance

  • The company

    Provide laboratory instruments and automation solutions for biopharmaceuticals, clinical diagnostics, and forensics

  • Latest results

    Quarter to June 30, 2026 · EPS CHF 0.99

TickerLandia's take on Tecan Group

Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks

Where the price stands

52-wk lowCHF 110.60
52-wk highCHF 278.00

−14.17% from the 52-week high

Analysts · 8 analysts

Average targetCHF 222.73−6.65% vs. price

Buy 3 · Hold 5 · Sell 0 · Buy

TickerLandia Fingerprint: Tecan Group

Compared with similar companies: very strong momentum, very low profitability, and very low growth.

Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.

Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 22, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated

Valuation

Tecan Group is pricier than similar companies

Tecan Group's Forward P/E: 30.4, +48% against the median of a group of 11 similar companies (20.6).

Compared with 11 similar companies

Tecan Group's metrics compared with similar companies
MetricTecan GroupPosition in the groupBand
Forward P/E30.4High
Operating margin4.9%Low
ROE-9.7%Low
Debt/equity0.19Low
Price/book2.69Middle

Grey band: the middle half of the group; tick: the median; dot: Tecan Group. All multiples and dividends

TickerLandia analysisHow it is calculated

The financials

The business in numbers

Revenue

CHF 427.53M

Latest quarter · Q2 2026

Net income

CHF 12.27M

Latest quarter · Q2 2026

Quarterly net margin

2.9%

Latest quarter · Q2 2026

Numbers and valuation

Full valuation
Market cap
CHF 3B
EPS
-CHF 9.01
Volume
48.91K
Daily trading
€18.69M
Dividend yield
1.26%
Last ex-dividend on April 17, 2026

How Tecan Group is changing

All results
  • Revenue grew 3.8% a year on average over the last 5 years

  • Operating margin fell from 12.9% to 5.1%

  • Shares outstanding up 5.2% in 5 years

Returns

Tecan Group returns with dividends

CHF 1,000 invested in Tecan Group 5 years ago, on November 22, 2021, would be worth CHF 445 today with dividends reinvested: −55.47% in total, −14.95% per year. On price alone it would be CHF 416 (−58.36%).

PeriodTecan GroupSMICHF 1,000 becomes
1 month−2.21%+0.65%CHF 978
6 months+64.44%+8.75%CHF 1,644
Year to date+85.68%+9.83%CHF 1,857
1 year+83.30%+16.18%CHF 1,833
3 years−17.23%+35.68%CHF 828
5 years−55.47%+16.48%CHF 445
10 years+62.31%+85.64%CHF 1,623

Over the last 6 months it has done better than 88% of the stocks in the Healthcare sector.

From 1 year up with dividends reinvested, before taxes; under a year price only. SMI: price only. Calculate your investment

The chart in detail

Tecan Group: technical analysis

Tecan Group is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 59.9% below its all-time closing high (CHF 594.50, August 23, 2021).

Trend
Upward
RSI (14 sessions)
46
Between 30 and 70
vs 200-session average
+35.66%

Support and resistance

Price areas where Tecan Group has stopped several times in the last year. They describe the chart; they are not forecasts.

  1. No resistance above: the price is near the highs of the year
  2. Last priceCHF 238.60
  3. SupportCHF 235.90−1.13%2 touches, last on November 3, 2026
  4. SupportCHF 201.50−15.55%2 touches, last on September 1, 2026
  5. SupportCHF 183.53−23.08%3 touches, last on August 26, 2026

Volatility and risk

Over the last year it has moved roughly in line with the SMI.

Beta (1 year) vs SMI
0.87
Volatility (60 sessions, annualised)
39.7%
Largest fall in the last year
−28.45%

Close of November 20, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it

Tecan Group: seasonality

Average monthly price change over 32 years

+1.0%Jan+2.6%Feb−0.7%Mar+1.0%Apr+3.7%May+0.2%Jun+0.7%Jul+2.3%Aug+0.1%Sep−0.1%Oct+4.0%Nov+3.4%Dec

Over the last 32 years, the strongest month for Tecan Group has been November: +3.96% on average, positive in 20 years out of 31. The weakest has been March: −0.68% on average, positive in 16 years out of 31.

Show chart data
MonthAverageMedianPositive years
January+1.00%+0.29%16 of 31
February+2.56%+0.28%17 of 31
March−0.68%+0.38%16 of 31
April+0.96%+3.16%18 of 31
May+3.73%+1.68%20 of 32
June+0.17%+1.04%17 of 32
July+0.71%+1.44%19 of 32
August+2.29%+1.91%20 of 32
September+0.13%+0.30%17 of 32
October−0.11%+0.19%16 of 32
November+3.96%+5.10%20 of 31
December+3.38%+5.08%21 of 31

Price change only, dividends excluded. Past seasonality does not predict future moves.

The company

Tecan Group and its competitors

Headquartered in Männedorf, Switzerland, the company was founded in 1980 and builds laboratory instruments for customers in biopharmaceutical, forensic and clinical diagnostics settings. Its Life Sciences Business covers liquid handling and automation systems, microplate readers and washers, laboratory software, consumables, sequencing reagents, and immunoassays and antibodies. The Partnering Business offers contract design and manufacturing through PARAMIT, while Tecan Labwerx provides an end-to-end automation solution.

Headquarters
Männedorf, Switzerland
Employees
3,000
Founded
1980
Chief executive
Monica Manotas
Tecan Group and its competitors
CompanyMarket capOperating marginP/E (trailing 12 months)6 months
Tecan GroupTECN$3.58B4.9%—+64.44%
SCHOTT Pharma1SXP$3.74B16.4%25.1+34.04%
Fielmann GroupFIE$3.93B13.7%16.4−3.95%
Carl Zeiss MeditecAFX$3.07B7.2%23.3+24.32%
OttobockOBCK$2.68B18.7%19.0−31.33%
AddLifeALIF.B$2.11B8.9%33.5+17.73%

Same industry or related industries, similar size. Compare Tecan Group with its competitors · Full profile